Article
Prognosis and personalized treatment prediction of IGF2BP2- mediated m6A modification patterns in pancreatic cancer
2023-01-04
Abstract excerpt
<h4>Background: </h4> Pancreatic cancer (PC) is a malignant digestive system tumor with a very poor prognosis. N6-methyladenosine (m6A) is mediated by a variety of readers and participates in important regulatory roles in PC. Therefore, it is necessary to screen out its specific modification mode from the m6A readers, and deeply explore its mechanism and its pharmacogenomic characteristics, so as to provide a new...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 36d08803-bd99-566c-a3a7-098db7e16391
- DOI
- 10.21203/rs.3.rs-2420342/v1
